Human Immunology News Volume 12.10 | Mar 19 2024

    0
    5







    2024-03-19 | HIN 12.10


    Human Immunology News by STEMCELL Technologies
    Vol. 12.10 – 19 March, 2024
    TOP STORY

    Antibody-Independent Protection against Heterologous SARS-CoV-2 Challenge Conferred by Prior Infection or Vaccination

    Researchers showed, through studies in mouse models lacking antibodies but maintaining functional B cells and lymphoid organs, that immunity conferred by prior infection or mRNA vaccination could protect against SARS-CoV-2 challenge independently of antibodies.
    [Nature Immunology]

    Full Article
    PUBLICATIONSRanked by the impact factor of the journal

    Evidence for Antigen Presentation by Human Neutrophils

    Investigators found that human cells were able to up-regulate HLA-DR and co-stimulatory molecules; were able to process protein antigen into fragments recognized by T cells; could enter lymph node T cell zones; and, in vitro, were able to present antigen to memory T cells, inducing proliferation and cytokine production.
    [Blood]

    Abstract

    Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

    Scientists highlighted the role of stromal tumor-infiltrating lymphocytes in patient selection/stratification for neo/adjuvant escalation and de-escalation strategies.
    [Clinical Cancer Research]

    Abstract

    Adipose Stem Cells Control Obesity-Induced T Cell Infiltration into Adipose Tissue

    Researchers underscored the pivotal role of adipose stem cells in regulating T cell accumulation in white adipose tissue during the early phases of obesity, emphasizing their importance in modulating adaptive immunity in obesity-induced adipose inflammation.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Th1 Cell Immune Response in Talaromyces marneffei Infection with Anti-Interferon-γ Autoantibody Syndrome

    A multicenter study of HIV-negative individuals with T. marneffei infection was conducted between September 2018 and 2020. Patients were divided into anti-interferon-γ autoantibody (AIGA)-positive and AIGA-negative groups according to the AIGA titer and neutralizing activity.
    [Microbiology Spectrum]

    Full Article

    Transmembrane TNF-TNFR2 Signaling as a Critical Immunoregulatory Node in Pancreatic Cancer

    Researchers described that cancer cell-neutrophil signaling circuitry provoked neutrophil-derived transmembrane TNF-TNFR2 interactions that dictated inflammatory polarization in cancer-associated fibroblasts and T cell dysfunction – two hallmarks of therapeutic resistance.
    [Oncoimmunology]

    Abstract

    Upregulation of HLA-II Related to LAG-3+ CD4+ T Cell Infiltration Is Associated with Patient Outcome in Human Glioblastoma

    Scientists investigated the expression and regulation of human leukocyte antigen-II in human glioblastoma samples and the correlation with lymphocyte-activation gene 3 (LAG-3)+CD4+ T cell infiltration.
    [Cancer Science]

    Abstract

    Raman Spectroscopy of Lymphocytes from Patients with the Epstein–Barr Virus Infection

    Raman spectroscopy was applied to trace lymphocytes activation following contact with the Epstein–Barr virus of the herpesvirus family. The biomarker of cell activation was found to be the 520 cm−1 band, indicating the formation of immunoglobulins.
    [Scientific Reports]

    Full Article

    Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation

    Researchers investigated the transcriptome of human bronchial epithelial cells in response to serum from patients with different degrees of inflammation. Serum from 19 COVID-19 patients obtained from the Hannover Unified Biobank was used.
    [Lung]

    Full Article
    Learn about immunological considerations for hPSC banking by watching Dr. David Turner's webinar from the Nature Research Round Table on hPSC Quality
    REVIEWS

    Blood-Based Biomarkers in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Blockade

    The authors review studies in which multiple blood-based biomarkers encompassing circulating soluble analytes, immune cell subsets, and circulating tumor cells have shown promising associations with the clinical response of non-small cell lung cancer patients to immune checkpoint inhibitors therapy.
    [Journal Of Experimental & Clinical Cancer Research]

    Full Article
    INDUSTRY AND POLICY NEWS

    TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region

    TaiMed Biologics signed an Exclusive License and Distribution Agreement with AcedrA BioPharmaceuticals to satisfy the unmet medical needs, under which AcedrA will register, promote, and commercialize Trogarzo® in the MENA region.
    [TaiMed Biologics (Globe Newswire)]

    Press Release
    FEATURED EVENT

    Systems and Engineering Immunology: Advancing Immunological Insights in Health and Disease

    April 9 – 12, 2024
    Fairmont Banff Springs, Alberta, Canada

    > See All Events

    JOB OPPORTUNITIES

    PhD Position – Immunology

    University of Oslo – Oslo, Norway

    Senior Researcher – Hematopoietic Stem Cell Biology and Leukemia

    Francis Crick Institute – London, England, United Kingdom

    PhD Student – Intestinal Tumorigenesis

    University of Montpellier – Montpellier, France

    Postdoctoral Position – Immunology of Airway Allergy and Asthma

    University of Denmark – Lyngby, Denmark

    Postdoctoral Scientist – Cancer Immunology and ECMs

    Foundation for Liver Research – London, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2